SCHEMBL3169130

SCHEMBL3169130

CC(=O)NCCNc1nc(-c2ccccc2)nc(NCCNC(=O)Cc2ccccc2)c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.61
ADORA1 P30542 2/20 0.61
ALDH1A1 P00352 6/20 0.53
CYP1A2 P05177 10/20 0.52
CYP3A4 P08684 9/20 0.52
CYP2D6 P10635 8/20 0.52
CLK4 Q9HAZ1 7/20 0.52
TSHR P16473 3/20 0.52
HSD17B10 Q99714 2/20 0.52
MAPT P10636 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ALOX15 P16050 2/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
RECQL P46063 1/20 0.52
HBB P68871 1/20 0.52
CYP2C19 P33261 4/20 0.49
CYP2C9 P11712 1/20 0.49
USP2 O75604 2/20 0.48
ADORA2B P29275 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165012 0.95 ADORA2A (0.59) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3171317 0.94 ADORA2A (0.58) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3259471 0.92 ADORA2A (0.53) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3262586 0.92 ADORA2A (0.56) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3172948 0.92 ADORA2A (0.55) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3172266 0.91 CYP1A2 (0.56) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3162050 0.90 ADORA2A (0.72) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3164662 0.88 ADORA2A (0.64) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3155823 0.88 ADORA2A (0.64) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3165164 0.88 CYP1A2 (0.63) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed